Suven Pharmaceuticals Limited

Informe acción NSEI:SUVENPHAR

Capitalización de mercado: ₹168.1b

Suven Pharmaceuticals Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Sudhir Singh

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOless than a year
Participación del CEOn/a
Permanencia media de la direcciónless than a year
Promedio de permanencia en la Junta Directivaless than a year

Actualizaciones recientes de la dirección

Recent updates

These 4 Measures Indicate That Suven Pharmaceuticals (NSE:SUVENPHAR) Is Using Debt Safely

Dec 15
These 4 Measures Indicate That Suven Pharmaceuticals (NSE:SUVENPHAR) Is Using Debt Safely

Robust Earnings May Not Tell The Whole Story For Suven Pharmaceuticals (NSE:SUVENPHAR)

Aug 03
Robust Earnings May Not Tell The Whole Story For Suven Pharmaceuticals (NSE:SUVENPHAR)

Does Suven Pharmaceuticals (NSE:SUVENPHAR) Have A Healthy Balance Sheet?

May 12
Does Suven Pharmaceuticals (NSE:SUVENPHAR) Have A Healthy Balance Sheet?

Suven Pharmaceuticals Limited (NSE:SUVENPHAR) Investors Are Less Pessimistic Than Expected

Mar 26
Suven Pharmaceuticals Limited (NSE:SUVENPHAR) Investors Are Less Pessimistic Than Expected

Here's Why We Think Suven Pharmaceuticals (NSE:SUVENPHAR) Is Well Worth Watching

Mar 07
Here's Why We Think Suven Pharmaceuticals (NSE:SUVENPHAR) Is Well Worth Watching

These 4 Measures Indicate That Suven Pharmaceuticals (NSE:SUVENPHAR) Is Using Debt Safely

Nov 30
These 4 Measures Indicate That Suven Pharmaceuticals (NSE:SUVENPHAR) Is Using Debt Safely

Do Suven Pharmaceuticals's (NSE:SUVENPHAR) Earnings Warrant Your Attention?

Sep 03
Do Suven Pharmaceuticals's (NSE:SUVENPHAR) Earnings Warrant Your Attention?

Here's Why Suven Pharmaceuticals (NSE:SUVENPHAR) Can Manage Its Debt Responsibly

Aug 04
Here's Why Suven Pharmaceuticals (NSE:SUVENPHAR) Can Manage Its Debt Responsibly

Analysts Have Made A Financial Statement On Suven Pharmaceuticals Limited's (NSE:SUVENPHAR) Full-Year Report

Jun 11
Analysts Have Made A Financial Statement On Suven Pharmaceuticals Limited's (NSE:SUVENPHAR) Full-Year Report

With EPS Growth And More, Suven Pharmaceuticals (NSE:SUVENPHAR) Is Interesting

Apr 13
With EPS Growth And More, Suven Pharmaceuticals (NSE:SUVENPHAR) Is Interesting

Does Suven Pharmaceuticals (NSE:SUVENPHAR) Have A Healthy Balance Sheet?

Mar 08
Does Suven Pharmaceuticals (NSE:SUVENPHAR) Have A Healthy Balance Sheet?

Can Suven Pharmaceuticals Limited's (NSE:SUVENPHAR) ROE Continue To Surpass The Industry Average?

Feb 08
Can Suven Pharmaceuticals Limited's (NSE:SUVENPHAR) ROE Continue To Surpass The Industry Average?

CEO

Sudhir Singh (58 yo)

less than a year

Permanencia

Dr. Sudhir Kumar Singh, Ph.D. serves as Chief Executive Officer since September 29, 2023 at Suven Pharmaceuticals Ltd. He served as Chief Operating Officer of Aragen Life Sciences Private Limited from Sept...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Vaidheesh Annaswamy
Executive Chairmanless than a yearsin datossin datos
Sudhir Singh
Chief Executive Officerless than a yearsin datossin datos
Himanshu Agarwal
Chief Financial Officerless than a yearsin datossin datos
K. Babu
Chief Quality & Compliance Officerno datasin datossin datos
Gaurav Bahadur
Chief Human Resources Officerless than a yearsin datossin datos
Vetukuri Venkata Naga Kali Vara Raju
MD & Directorno datasin datossin datos
Subba Komaravolu
Chief Strategy Officerless than a yearsin datossin datos
Brian Shaughnessy
Chief Commercial Officerless than a yearsin datossin datos
K. Rao
Company Secretaryno datasin datossin datos
Sunder Venkatraman
Vice President of Corporate Affairs3.3yrssin datossin datos

0.6yrs

Permanencia media

55.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de SUVENPHAR no se considera experimentado ( 0.6 años antigüedad media), lo que sugiere un nuevo equipo.


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Vaidheesh Annaswamy
Executive Chairmanless than a yearsin datossin datos
Vetukuri Venkata Naga Kali Vara Raju
MD & Directorless than a yearsin datossin datos
Abhijit Mukherjee
Member of Advisory Councilless than a yearsin datossin datos
Venkateswarlu Jasti
Member of Advisory Councilless than a year₹98.16m0.00079%
₹ 1.3m
Shweta Jalan
Non-Executive Directorless than a yearsin datossin datos
Pankaj Patwari
Non-Executive Directorless than a yearsin datossin datos
Vinod Rao
Independent Directorless than a yearsin datossin datos
Matangi Gowrishankar
Independent Directorless than a yearsin datossin datos
Stefan Stoffel
Member of Advisory Councilless than a yearsin datossin datos
Pravin Udhyavara Rao
Independent Directorless than a yearsin datossin datos
Kumarapuram Ananthakrishnan
Independent Directorless than a yearsin datossin datos

0.6yrs

Permanencia media

62yo

Promedio de edad

Junta con experiencia: La junta directiva de SUVENPHAR no se considera experimentada (0.6 años de permanencia promedio), lo que sugiere una nueva junta directiva.